← SynDRA
MOFEZOLAC
SynDRA canonical compound SYN0008948 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | PTGS1 |
|---|
| Mechanism of action | cyclooxygenase inhibitor |
|---|
| Indication | osteoporosis | rheumatoid arthritis |
|---|
| Disease area | orthopedics | rheumatology |
|---|
All known targets
Mechanisms of action (all sources)
- PTGS1 INHIBITOR
- cyclooxygenase inhibitor
Drug classes
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Antirheumatic Agents
- Cyclooxygenase Inhibitors
- Enzyme Inhibitors
- Peripheral Nervous System Agents
- Sensory System Agents
Cross-references
Synonyms
- N-22
- Mofezolaco
- Mofezolacum
- RVJ0BV3H3Y
- (3,4-bis(4-methoxyphenyl)-5-isoxazolyl)acetic acid
- DTXCID9026716
- 3,4-DMPIAA
- N-22 compound
- [3,4-bis(4-methoxyphenyl)-5-isoxazolyl]acetic acid
- (3,4-di-(4-methoxyphenyl)-5-isoxazolyl)acetic acid
- RefChem:159308
- Disopain
- 2-(3,4-bis(4-methoxyphenyl)isoxazol-5-yl)acetic acid
- Mofezolac [INN]
- 2-[3,4-bis(4-methoxyphenyl)-1,2-oxazol-5-yl]acetic acid
- 5-Isoxazoleacetic acid, 3,4-bis(4-methoxyphenyl)-
- 3,4-bis(p-Methoxyphenyl)-5-isoxazoleacetic acid
- NCGC00167563-01
- 2-[3,4-bis(4-methoxyphenyl)isoxazol-5-yl]acetic acid
- [3,4-bis(4-methoxyphenyl)-1,2-oxazol-5-yl]acetic acid
- Mofezolacum [INN-Latin]
- Mofezolaco [INN-Spanish]
- CCRIS 4316
- UNII-RVJ0BV3H3Y
- BRN 5986171
- Mofezolac?
- DJEIHHYCDCTAAH-UHFFFAOYSA-N
- Mofezolac (TN)
- 3,4-Bis(4-methoxyphenyl)-5-isoxazoleacetic acid
- 3,4-Bis((4-methoxyphenyl)-5-isooxazolyl)acetic acid
- Acetic acid, 3,4-bis(4-methoxyphenyl)-5-isooxazolyl-
- Mofezolac (JAN/INN)
- MOFEZOLAC [JAN]
- MOFEZOLAC [MI]
- CBKinase1_012222
- CBKinase1_024622
- MOFEZOLAC [MART.]
- MOFEZOLAC [WHO-DD]
Look up MOFEZOLAC in the interactive SynDRA portal →